Covid-19 roundup: The FDA gives Moderna’s Covid-19 team a regulatory embrace to go along with the cheers and jeers; BioNTech expects first coronavirus data in a matter of weeks
The FDA offered a little extra public assurance today that Moderna could expect an open door every time execs come knocking as they piece together …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
